FINWIRES · TerminalLIVE
FINWIRES

Al Rajhi Capital Downgrades Jamjoom Pharmaceuticals Factory to Neutral, Lowers PT

By

Al Rajhi Capital on Wednesday downgraded pharmaceutical company Jamjoom Pharmaceuticals Factory (SASE:4015) to neutral from overweight and reduced its price target to 155 Saudi riyals from 175 riyals.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

Related Articles